The US Food and Drug Administration has issued guidance to help clinical investigators meet their responsibilities with respect to protecting human subjects and ensuring the integrity of data when conducting trials1,2.
The guidance also clarifies the FDA’s expectations concerning investigators’ responsibility for supervising a clinical study in which some study tasks are delegated to the employees of the investigators or to outside parties...
Please login to read the full article.
